MKS Instruments Inc (MKSI)vsNovanta Inc (NOVT)
MKSI
MKS Instruments Inc
$267.31
+2.09%
TECHNOLOGY · Cap: $17.95B
NOVT
Novanta Inc
$146.56
+1.84%
TECHNOLOGY · Cap: $5.65B
Smart Verdict
WallStSmart Research — data-driven comparison
MKS Instruments Inc generates 322% more annual revenue ($4.35B vs $1.03B). MKSI leads profitability with a 10.1% profit margin vs 6.0%. MKSI appears more attractively valued with a PEG of 1.32. MKSI earns a higher WallStSmart Score of 69/100 (B-).
MKSI
Strong Buy69
out of 100
Grade: B-
NOVT
Buy54
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-59.8%
Fair Value
$162.14
Current Price
$267.31
$105.17 premium
Margin of Safety
-39.9%
Fair Value
$101.39
Current Price
$146.56
$45.17 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 162.0% YoY
Strong operational efficiency at 20.6%
Revenue surging 28.3% year-over-year
Earnings expanding 150.0% YoY
Conservative balance sheet, low leverage
Areas to Watch
Elevated debt levels
Premium valuation, high expectations priced in
Distress zone — elevated risk
Expensive relative to growth rate
ROE of 5.2% — below average capital efficiency
6.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MKSI
The strongest argument for MKSI centers on EPS Growth, Operating Margin, Revenue Growth. Revenue growth of 28.3% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bull Case : NOVT
The strongest argument for NOVT centers on EPS Growth, Debt/Equity. Revenue growth of 10.3% demonstrates continued momentum.
Bear Case : MKSI
The primary concerns for MKSI are Debt/Equity, P/E Ratio, Altman Z-Score. A P/E of 42.3x leaves little room for execution misses.
Bear Case : NOVT
The primary concerns for NOVT are PEG Ratio, Return on Equity, Profit Margin. A P/E of 94.5x leaves little room for execution misses.
Key Dynamics to Monitor
MKSI profiles as a growth stock while NOVT is a value play — different risk/reward profiles.
MKSI carries more volatility with a beta of 1.97 — expect wider price swings.
MKSI is growing revenue faster at 28.3% — sustainability is the question.
MKSI generates stronger free cash flow (189M), providing more financial flexibility.
Bottom Line
MKSI scores higher overall (69/100 vs 54/100) and 28.3% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MKS Instruments Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.
Visit Website →Novanta Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?